Global gene expression changes during neoadjuvant chemotherapy for human breast cancer

Cancer Journal

Volumn 8, Issue 6, 2002, Pages 461-468

  Buchholz, Thomas A ^a,c   Stivers, David N ^a   Stec, James ^b   Ayers, Mark ^b   Clark, Edward ^b   Bolt, Andrew ^b   Sahin, Aysegul A ^a   Symmans, W Fraser ^a   Hess, Kenneth R ^a   Kuerer, Henry M ^a   Valero, Vicente ^a   Hortobagyi, Gabriel N ^a   Pusztai, Lajos ^a  

^a UNIVERSITY OF TEXAS   (United States)

^b MILLENNIUM PHARMACEUTICALS INC   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

Breast cancer; Chemotherapy response; DNA microarray; Gene expression

Indexed keywords

COMPLEMENTARY DNA; CYCLOPHOSPHAMIDE; DOCETAXEL; DOXORUBICIN; FLUOROURACIL; PACLITAXEL; RNA;

ANALYSIS OF VARIANCE; ARTICLE; BREAST BIOPSY; BREAST CANCER; CANCER ADJUVANT THERAPY; CANCER PATIENT; CLINICAL ARTICLE; CLUSTER ANALYSIS; COMPARATIVE STUDY; CONTROLLED STUDY; DNA HYBRIDIZATION; DNA MICROARRAY; DNA PROBE; DNA SYNTHESIS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE SEQUENCE; GENETIC TRANSCRIPTION; HUMAN; HUMAN TISSUE; ISOTOPE LABELING; MOLECULAR CLONING; PATHOLOGY; PREMEDICATION; PREOPERATIVE PERIOD; PRIORITY JOURNAL; RNA EXTRACTION; TREATMENT RESPONSE; TUMOR BIOPSY; ADJUVANT THERAPY; BIOPSY; BREAST TUMOR; DRUG EFFECT; DRUG MONITORING; GENE EXPRESSION; GENETICS; METHODOLOGY; PILOT STUDY; REGRESSION ANALYSIS; REPRODUCIBILITY;

ANALYSIS OF VARIANCE; BIOPSY; BREAST NEOPLASMS; CLUSTER ANALYSIS; DRUG MONITORING; FEMALE; GENE EXPRESSION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; NEOADJUVANT THERAPY; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PILOT PROJECTS; REGRESSION ANALYSIS; REPRODUCIBILITY OF RESULTS; RNA, NEOPLASM;

EID: 0036836249     PISSN: 15289117     EISSN: 1540336X     Source Type: Journal    
DOI: 10.1097/00130404-200211000-00010     Document Type: Article

References (11)

1. Harvey JM, Clark GM, Osborne CK et al. Estrogen receptor status by immunohistochemistry is superior to the ligand-binding assay for predicting response to adjuvant endocrine therapy in breast cancer. J Clin Oncol 1999;17:1474-1481.
2. Slamon DJ, Leyland-Jones B, Shak S et al. Use of chemotherapy plus a monoclonal antibody against HER2 for metastatic breast cancer that overexpresses HER2. N Engl J Med 2001;44:783-792.
3. Perou CM, Serlie T, Eisen MB et al. Molecular portraits of human breast tumours. Nature 2000;406:747-752.
4. Gruvberger S, Ringner M, Chen Y et al. Estrogen receptor status in breast cancer is associated with remarkably distinct gene expression patterns. Cancer Res 2001;61:5979-5984.
5. Pusztai L, Ayers M, Stec J et al. Gene expression profiles obtained from single passage fine needle aspirations (FNA) of breast cancer reliably identify prognostic/predictive markers such as estrogen (ER) and HER-2 receptor status and reveal large scale molecular differences between ER-negative and ER-positive tumors. Clin Cancer Res 2002; submitted for publication.
6. Hedenfalk I, Duggan D, Chen Y et al. Gene-expression profiles in hereditary breast cancer. N Engl J Med 2001;344:539-548.
7. van't Veer LJ, Dai H, van de Vijver, MJ et al. Gene expression profiling predicts clinical outcome of breast cancer. Nature 2002;415:530-536.
8. Lonning PE, Sorlie T, Perou CM et al. Microarrays in primary breast cancer-lessons from chemotherapy studies. Endocr Relat Cancer 2001;8:259-263.
9. Meyn RE, Stephens LC, Hunter NR et al. Kinetics of cisplatin-induced apoptosis in murine mammary and ovarian adenocarcinomas. Int J Cancer 1995;60:725-729.
10. Symmans WF, Volm MD, Shapiro RL et al. Paclitaxel-induced apoptosis and mitotic arrest assessed by serial fine-needle aspiration: implications for early prediction of breast cancer response to neoadjuvant treatment. Clin Cancer Res 2000;6:4610-4617.
11. Chang J, Ormerod M, Powles TJ et al. Apoptosis and proliferation as predictors of chemotherapy response in patients with breast carcinoma. Cancer 2000;89:2145-2152.